AcquisitionOther
Vascular Biogenics Ltd. acquired target
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Vascular Biogenics Ltd. -> target · $10.3 million
("Notable"), a clinical stage therapeutic platform company developing predictive precision medicines for cancer patients, today announced they have entered into a definitive merger agreement.
Open source record (SEC) ↗